Proteins and Drug Discovery Set: Rsc

The books in this set cover important protein drug targets, current drug leads, and biological mechanisms underpinning cutting-edge therapeutic strategies. At the interface between chemical biology, molecular pharmacology, medicinal chemistry and biophysics, this set will provide an invaluable reference for medicinal chemists, emerging drug discovery scientists, researchers in industry, and scientists interested in proteomics.

This set includes:

Kinase Drug Discovery Edited by Richard A Ward and Frederick Goldberg (978-1-84973-174-4, 2011, RSC Drug Discovery)

Proteinases as Drug Targets Edited by Ben Dunn (978-1-84973-049-5, 2011, RSC Drug Discovery)

New Therapeutic Strategies for Type 2 Diabetes: Small Molecule Approaches Edited by Rob M Jones (978-1-84973-414-1, 2012, RSC Drug Discovery)

Inhibitors of Molecular Chaperones as Therapeutic Agents Edited by Timothy D Machajewski and Zhenhai Gao (978-1-84973-666-4, 2013, RSC Drug Discovery)

Extracellular and Intracellular Signaling Edited by James D Adams and Keith Parker (978-1-84973-160-7, 2011, RSC Drug Discovery)

G Protein-Coupled Receptors: From Structure to Function Edited by Jesus Giraldo and Jean-Philippe Pin (978-1-84973-183-6, 2011, RSC Drug Discovery)

Protein and Peptide Analysis by LC-MS: Experimental Strategies Edited by Thomas Letzel (978-1-84973-182-9, 2011, RSC Chromatography Monographs)

Successful Strategies for the Discovery of Antiviral Drugs Edited by Manoj C Desai and Nicholas A Meanwell (978-1-84973-657-2, 2013, RSC Drug Discovery)